Literature DB >> 2824022

Characterization and frequency distribution of lymphoreticular infiltrates in axillary lymph node metastases of invasive ductal carcinoma of the breast.

H A Horst1, H P Horny.   

Abstract

One hundred and seventy-five axillary lymph nodes containing metastatic deposits from 46 invasive ductal carcinomas of the breast were evaluated histologically and immunohistologically. The study yielded the following results: (1) tumor-infiltrating lymphoreticular cells preferentially accumulated in the stromal bands; the tumor foci generally showed a considerably lower degree of infiltration; (2) in most cases, monocytes/macrophages (Mono 1+) represented the overwhelming majority of tumor-infiltrating cells; (3) next in frequency were T-lymphocytes (Leu-1+), especially CD4+ lymphocytes (Leu-3a+), while CD8+ lymphocytes (Leu-2a+) mostly occurred only in moderate numbers; (4) B-lymphocytes (To15+), plasma cells, natural killer cells (Leu-7+), tissue mast cells, and T-accessory reticulum cells (OKT 6+) were observed mostly in low or very low numbers, while eosinophils were nearly absent and B-accessory reticulum cells (Ki-M4+) were totally absent from the lymphoreticular infiltrates. Definite conclusions regarding the functional properties of the tumor-infiltrating cells cannot be drawn from an immunohistologic analysis in situ alone, but the preferred localization of most tumor-infiltrating cells in the stroma does not support an intensive interaction between the host defenses and the metastatic tumor.

Entities:  

Mesh:

Year:  1987        PMID: 2824022     DOI: 10.1002/1097-0142(19871215)60:12<3001::aid-cncr2820601224>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  HLA expression and tumor-infiltrating immune cells in uveal melanoma.

Authors:  I de Waard-Siebinga; C G Hilders; B E Hansen; J L van Delft; M J Jager
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

2.  Soluble factors produced by macrophages/monocytes inhibit lymphokine-activated killer activity in rat splenocyte cultures.

Authors:  P J Kuppen; A M Eggermont; R B Quak; A Marinelli; C J van de Velde; G J Fleuren
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

Review 3.  Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.

Authors:  R Clarke
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells.

Authors:  Kristina A Szabo; Gurmit Singh
Journal:  Breast Cancer Res       Date:  2005-06-14       Impact factor: 6.466

5.  'Macrophages' and their putative significance in human breast cancer.

Authors:  J P van Netten; B J Ashmed; D Cavers; C Fletcher; I G Thornton; B L Antonsen; P Coy; M L Brigden
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.